Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo

Diagnostics company Alere Inc., has announced today that it has received U.S. FDA approval of its pre-market application to market Alere Determine™ HIV 1/2 Ag/Ab Combo in the United States for the detection of HIV-1 p24 antigen and antibodies to HIV-1/HIV-2.

Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo (via PR Newswire)

WALTHAM, Mass., Aug. 9, 2013 /PRNewswire/ — Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information, announced today that it has received…

published: August 12, 2013 in: Approval/Clearance

Most read

Latest

^